TITLE

Tighten co-pays to reflect medical value

AUTHOR(S)
Shepherd, Leah Carlson
PUB. DATE
January 2006
SOURCE
Employee Benefit News;Jan2006, Vol. 20 Issue 1, p36
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article focuses on the tightening of co-payments in medical insurance which was discussed during the National Business Coalition on Health conference in the U.S. on November 15, 2005. A scenario on co-payments was discussed by Mark Fendrick, an internist and associate professor of health management and policy at the University of Michigan. In this article, co-payments for generic drugs by employees and retirees in Massachusetts are discussed.
ACCESSION #
19469331

 

Related Articles

  • High court health reform ruling could spawn further legislation. HARRISON, SHEENA // Business Insurance;5/28/2012, p4 

    The article discusses the highlights of the discussion on the Patient Protection and Affordable Care Act at WorldatWork's Total Rewards 2012 Conference & Exhibition. A possibility on the inability of the Supreme Court to rule on whether the individual mandate is constitutional is cited due the...

  • Cutting Prices to Save Sales. Greb, Erik // Pharmaceutical Technology;Jan2012, Vol. 36 Issue 1, p14 

    The article presents the author's insights on the advantages and disadvantages of the copay coupons offered by various drug companies such as Pfizer to take a lead ahead of its generic drug competitors.

  • Greater co-payment incentives needed for use of generics.  // PharmacoEconomics & Outcomes News;9/20/2008, Issue 562, p5 

    The article reports on the insufficiency of the current co-payment differences between branded and generic drugs in tiered formularies for the majority of patients to choose generics, based on a 2008 survey in the U.S. It was discussed at the International Conference on Pharmacoepidemiology and...

  • Explaining commercial interests to patients. Tanzi, Maria G. // Pharmacy Today;Oct2012, Vol. 18 Issue 10, p30 

    The article offers information on various strategies implemented by manufacturers including copayment cards for branded products, marketing of patent extenders, and authorized generics, that allows consumers to aware of the drugs in the U.S. It mentions that discount cards are used by...

  • TRICARE Drug Co-Pays Will Rise on Feb. 1. Lunney, Kellie // Government Executive;1/7/2016, p1 

    The article reports that co-payments for brand-name drugs and certain generic medications will increase between 2 and 4 dollars due to changes required by the fiscal 2016 National Defense Authorization Act. Co-pays for brand-name prescription drugs obtained through home delivery will increase...

  • Trends in Patient Cost Sharing for Clinical Services Used as Quality Indicators. Chernew, Michael; Gibson, Teresa B.; Fendrick, A. Mark // JGIM: Journal of General Internal Medicine;Mar2010, Vol. 25 Issue 3, p243 

    Patient copayments for all medical services have increased dramatically. There are few data available regarding how copayments have changed for services commonly considered to be quality indicators. Describe the relative change in copayments for services used as quality indicators and...

  • Generics Event Set for November.  // Chain Drug Review;9/27/2010, Vol. 32 Issue 16, p60 

    The article offers information about the third annual Generic Medicines World Congress Americas conference to be held in Washington, D.C.. from November 16-18, 2010.

  • Don't let lunch money bandits steal you blind. Pennachio, Dorothy L. // Medical Economics;8/23/2002, Vol. 79 Issue 16, p45 

    Advises physicians to be stricter in managing copay embezzling by employees. Need to enforce a bookkeeping system that will deter would-be embezzlers; Danger that petty embezzling would lead to bigger thefts; Strategies to prevent theft. INSET: Can you 'embezzle-proof' your practice?.

  • Consumers abandon Rx drugs, turn to generics.  // Drug Topics;Jun2009, Vol. 153 Issue 6, p12 

    The article reports on the analysis conducted by publisher Wolters Kluwer Health (WKH), which showed an increase in the consumers' shift towards generic drugs in the U.S. by 34 percent since 2006. The report revealed that copayments also increased together with prescription abandonment. Mark...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics